[{"AccountsPayableCurrent_0_Q1_USD":2518000.0,"AmortizationOfFinancingCosts_1_Q1_USD":356000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":3047000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3965000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":5052000.0,"OtherLiabilitiesCurrent_0_Q1_USD":1316000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-1846000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":14400000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":122000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":187192000.0,"TreasuryStockValue_0_Q1_USD":2638000.0,"TreasuryStockShares_0_Q1_shares":51409.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":9590000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":5.39,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":23000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":200000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":5000.0,"InterestExpenseDebt_1_Q1_USD":3403000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-1978000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":1437000.0,"DeferredRevenueCurrent_0_Q1_USD":3113000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-27842000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":185918000.0,"OtherAssetsNoncurrent_0_Q1_USD":6590000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-132000.0,"MarketableSecuritiesCurrent_0_Q1_USD":57474000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3965000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q1_USD":2498000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.015,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":1.336,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":1.426,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":411000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":6900000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":0.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":57606000.0,"OtherNoncashIncomeExpense_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-132000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-1846000.0,"LongTermDebtPercentageBearingFixedInterestRate_0_Q1_pure":0.0375,"InvestmentIncomeNet_1_Q1_USD":436000.0,"ImpairmentOfInvestments_1_Q1_USD":0.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-1166000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":363000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":373000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-73000.0,"DeferredRevenueNoncurrent_0_Q1_USD":2500000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_security":14.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":105012000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":57474000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":57606000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":132000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":0.0,"Goodwill_0_Q1_USD":49988000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.006,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":373000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":373000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1457665000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":10795000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":185918000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10977000.0,"NetIncomeLoss_1_Q1_USD":-25864000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-23110000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-57728000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":185923000.0,"LiabilitiesCurrent_0_Q1_USD":18982000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":328068000.0,"Liabilities_0_Q1_USD":352039000.0,"Revenues_1_Q1_USD":3377000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-4521000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.58,"CostsAndExpenses_1_Q1_USD":26274000.0,"CommonStockValue_0_Q1_USD":539000.0,"CommonStockSharesOutstanding_0_Q1_shares":53854913.0,"CommonStockSharesIssued_0_Q1_shares":53906322.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":179881000.0,"AssetsCurrent_0_Q1_USD":255232000.0,"Assets_0_Q1_USD":328068000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4968953.0,"AdditionalPaidInCapital_0_Q1_USD":1450279000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-14486000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9379000.0,"StockholdersEquity_0_Q1_USD":-23971000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":44421000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":10004000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":373000.0,"DebtInstrumentFaceAmount_0_Q1_USD":325000000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":125000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":5052000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":10817000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-8450000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":3965000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":16895000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":2000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"OperatingIncomeLoss_1_Q1_USD":-22897000.0,"InterestPayableCurrent_0_Q1_USD":2031000.0,"InterestPaidNet_1_Q1_USD":6094000.0,"InterestExpense_1_Q1_USD":3403000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5765000.0,"DepreciationAndAmortization_1_Q1_USD":925000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":320967000.0,"CommonStockSharesAuthorized_0_Q1_shares":600000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":373000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":4033000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]